Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators Piperazine-compounds

 Method of forming an image with photographic likeness on chocolate
It is an object of the present invention to economically create a quality photographic image with ...


 6-Acylamino-penam-3-carboxylic and 7-acylamino-3-cephem-4-carboxylic acids
We claim: 1. A compound of the formula I ##STR11## wherein the grouping -S-A- represents a radical ...


 Dry pesticidal compositions
What is claimed is: 1. A dry pesticidal composition of a toxicant useful for crops having a melting ...


 Amino acid solution for intravenous nutrition
OF THE PREFERRED EMBODIMENTS In the study leading to the present invention a rat whose small ...


 Warm two tone flavored dentifrice
I claim: 1. An anhydrous heat releasing fluoride dentifrice which generates heat in the mouth ...


 Toothpaste with zeolite polishing agent
We claim: 1. In an aqueous toothpaste composition having about 15-60% by weight polishing agent, ...


 Stabilized enzymatic dentifrice containing B-D-glucose and glucose oxidase
The enzymatic dentifrice of this invention comprises an enzyme system containing an oxidizable ...


 Method and composition for prevention of plaque formation and plaque dependent diseases
I claim: 1. A method for preventing periodontitis in the oral cavity, said method comprising the ...


 6-Aminopenicillanic acid sulfoxide silyl esters
I claim: 1. 6-aminopenicillanic acid sulfoxide silyl esters of the formula ##STR4## wherein R is ...


 Cephalosporin esters
What I claim is: 1. A compound having the formula: ##STR12## , wherein A is phenylacetamido, ...


 Piperazine compounds

Details
Inventors: Naylor, Alan; Judd, Duncan B.; Brown, Dearg S.;
Assignee: Glaxo Group Limited (London, GB)
Primary Examiner: Shen; Cecilia
Assistant Examiner:
Attorney, Agent or Firm: Bacon & Thomas

Compounds are disclosed of formula (I) ##STR1## wherein R.sub.1 represents --COR.sub.4, --CO.sub.2 R.sub.4 or --COCO.sub.2 R.sub.4 (where R.sub.4 represents a hydrogen atom or an unsubstituted or substituted C.sub.1-10 hydrocarbon moiety); R.sub.2 and R.sub.3 are the same or different and are C.sub.1-6 alkyl or C.sub.3-6 alkenyl; or --NR.sub.2 R.sub.3 forms a 5-membered (optionally containing an oxygen atom adjacent to the nitrogen) or 6-membered ring, which ring optionally contains one unit of unsaturation and which is unsubstituted or substituted by optionally substituted methylidene, --COR.sub.5 (where R.sub.5 represents C.sub.1-6 alkyl, --OR.sub.6 or --NHR.sub.6 and R.sub.6 represents hydrogen, C.sub.1-6 alkyl, aryl, or ar(C.sub.1-6)alkyl, or N.dbd.NOR.sub.7 (where R.sub.7 represents C.sub.1-6 alkyl); X represents a direct bond, --CH.sub.2 -- or --CH.sub.2 O--; Ar represents a substituted phenyl moiety; and physiologically acceptable salts thereof. The compounds are indicated as useful in the treatment of pain and cerebral ischaemia. Processes and intermediates for their preparation and pharmaceutical compositions containing them are also disclosed.

DETAILED DESCRIPTION We claim: 1.
A compound of formula (I) ##STR16## wherein R.
sub.
1 represents --COR.
sub.
4, --CO.
sub.
2 R.
sub.
4 or --COCO.
sub.
2 R.
sub.
4 (where R.
sub.
4 represents a hydrogen atom or a C.
sub.
1-6 alkyl or c.
sub.
2-6 alkenyl group; R.
sub.
2 and R.
sub.
3 are the same or different and are C.
sub.
1-6 alkyl or C.
sub.
3-6 alkenyl; or --NR.
sub.
2 R.
sub.
3 forms a 5-membered (optionally containing an oxygen atom adjacent to the nitrogen) or 6-membered ring, which ring optionally contains one unit of unsaturation and which is unsubstituted or substituted by methylidene optionally substituted by a group selected from nitrile, phenyl, carboxyl, amido, C.
sub.
1-6 alkyl, phen(C.
sub.
1-6)alkyl, C.
sub.
1-6 hydroxyalkyl, C.
sub.
1-6 carboxyalkyl and C.
sub.
1-6 amidoalkyl, --COR.
sub.
5 (where R.
sub.
5 represents C.
sub.
1-6 alkyl, --OR.
sub.
6 or --NHR.
sub.
6 and R.
sub.
6 represents hydrogen, C.
sub.
1-6 alkyl, phenyl, or phen(C.
sub.
1-6)alkyl or .
dbd.
NOR.
sub.
7 (where R.
sub.
7 represents C.
sub.
1-6 alkyl); X represents a direct bond, --CH.
sub.
2 --or --CH.
sub.
2 O--; Ar represents a phenyl moity substituted by one or more groups or atoms selected from halogen atoms, C.
sub.
1-6 alkyl, --CF.
sub.
3 and NO.
sub.
2 groups, or by two substituents which form a second ring; or a physiologically acceptable salt thereof.
2.
A compound according to claim 1 wherein R.
sub.
1 represents --COR.
sub.
4.
3.
A compound according to claim 1 wherein R.
sub.
1 represents --CO.
sub.
2 R.
sub.
4.
4.
A compound according to claim 1 wherein --NR.
sub.
2 R.
sub.
3 represents a pyrrolidine ring.
5.
A compound according to claim 1 wherein X represents --CH.
sub.
2 -- and Ar represents halosubstituted phenyl.
6.
A compound according to claim 1 wherein R.
sub.
4 represents --CH.
sub.
3, --CH.
sub.
2 CH.
sub.
3, --CH.
dbd.
CH.
sub.
2, --OCH.
sub.
3 or --OCH.
sub.
2 CH.
sub.
3.
7.
A compound selected from 4-Acetyl-1-[(3,4-dichlorophenyl)acetyl]-2-(1-pyrrolidinylmethyl)piperazine; 1-[(3,4-Dichlorophenyl)acetyl]-4-(1-oxo-2-propenyl)-2-(1-pyrrolidinylmethyl )piperazine; 1-[(3,4-Dichlorophenyl)acetyl]-4-(1-oxopropyl)-2-(1-pyrrolidinylmethyl)pipe razine; 4-Acetyl-1-[(3,4-dichlorophenyl)acetyl]-2-(1,2,3,6-tetrahydro-1-pyridinylme thyl)piperazine; Ethyl 4-[(3,4-dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-1-piperazinecarbox ylate; Methyl 4-[(3,4-dichlorophenyl)acetyl]-3-(1,2,3,6-tetrahydro-1-pyridinylmethyl)-1- piperazinecarboxylate; or a physiologically acceptable salt thereof



Related patents
  Insecticidal heterocyclic compounds
What is claimed is: 1. A heterocyclic compound of the formula: ##STR59## wherein A represents 2-chloropyridin-5-yl or 2-chlorothiazol-5-yl; Z.sup.1 represents O; R.sup.2 ...
  Self-locking cerebral electrical probe
In view of the foregoing objects, the instant invention contemplates a cerebral probe for stereoelectroencephalographic exploration which comprises a long, hollow, ...
  Transvenous cardiovascular integrated lead anchoring sleeve, protector, and permanent lead introducer stop gap
The present invention overcomes the problems inherent in the prior art apparatus and techniques by employing a suturing sleeve which is permanently attached about the ...
  Ear canal electrode
It is an object of this invention to provide a noninvasive external ear canal electrode with reduced electrical resistance and greater electrical sensitivity. It is a ...
  Method of reducing the level of low density lipoproteins in the serum of a patient
What is claimed is: 1. A method for reducing the level of low density lipoproteins in the serum of a patient which comprises, administering human fibroblast interferon ...
  7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
What we claim is: 1. A compound of the formula: R.sub.d.sup.1 --A.sup.14 --R.sup.e in which R.sub.d.sup.1 is aminopyridyl, protected aminopyridyl, aminopyrimidinyl or ...
  Synthesis of vincaminic acid derivatives
I claim: 1. A process for the preparation of vincaminic acid derivatives of formula ##STR4## in which R is methyl or ethyl and X is hydroxy or hydrogen and Y is hydrogen ...
  Certain N-phenyl or N-pyridyl aza sulfonium salts
OF THE INVENTION More specifically, this invention provides an improved process for making azasulfonium salt intermediates which are useful for making indoles which are ...
  Apparatus for treating finely divided materials with gaseous fluid
My invention aims to provide a method which does not present the aforementioned disadvantages and in which lumps formed in the first stage owing to clotting, can be ...
  Flavoring compositions containing dialkyl-.alpha.,.beta.-diacyl succinates
What is claimed is: 1. A flavor composition comprising a flavor component and 0.0001% to 30% by weight of a dialkyl-.alpha.,.beta.-diacyl succinate having the formula: ##...

0.044

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved